患者输血前进行血液病毒标志物检测的临床价值

王卫才

（陕西省商洛市商州区妇幼保健院，陕西 商洛，726000）

浏览次数：103次 下载次数：371次

摘要：

目的 探讨患者输血前进行血液病毒标志物检测的临床价值。方法 抽取2014年4月至2015年4月我院接诊的864例输血患者作为研究对象，在输血前对所有患者进行血液病毒标志物检测，包括人类免疫缺陷病毒抗体（抗-HIV）、乙型肝炎 病毒表面抗原（HBsAg）、梅毒螺旋体抗体（抗-TP）及丙型肝炎病毒抗体（抗-HCV），对检测结果进行分析。结果 抗-HIV 阳性 检出率为0.00%，HBsAg 阳性检出率为10.19%，抗-TP 阳性检出率为0.81%，抗-HCV 阳性检出率为0.93%，血液病毒标志物 总阳性检出率为11.92%；男性患者抗-TP 阳性、抗-HCV 阳性检出率与女性患者比较，无明显差异（P跃0.05）；男性患者HB原 sAg阳性检出率显著高于女性患者（P<0.05）。结论 在患者输血前对其进行血液病毒标志物检测，能及时掌握患者血液情况，降低传染性疾病传播风险，为患者生命健康提供保障。

关键词：输血前；血液病毒标志物；临床价值

中图分类号：R446.6文献标志码：A文章编号：2096-1413(2017)31-0134-02

Clinical value of blood virus markers detection before blood transfusion
WANG Wei-cai
(Shangzhou District Maternal and Child Health Care Hospital, Shangluo 726000, China)

ABSTRACT: Objective To discuss the clinical value of blood viral markers detection before blood transfusion. Methods Eight hundred and sixty-four patients with blood transfusion from April 2014 to April 2015 in our hospital were selected as the research objects. Before transfusion, all the patients were performed blood viral detection, including human immunodeficiency virus antibodies (anti-HIV), hepatitis B virus surface antigen (HBsAg), treponema pallidum antibody (anti-TP) and hepatitis C virus antibodies (anti-HCV), then the testing results were analyzed. Results The positive detection rate of anti-HIV, HBsAg, anti-TP and anti-HCV were 0.00%, 10.19%, 0.81% and 0.93% respectively, the total positive detection rate of blood virus markers was 11.92%. The positive detection rates of anti-TP and anti-HCV in the male patients were not significantly different from those in the female patients (P>0.05). The positive detection rate of HBsAg in the male patients was significantly higher than that in the female patients (P<0.05). Conclusion Performing blood viral markers detection before blood transfusion can grasp the situation of blood promptly, reduce the risk of infectious disease, and provide guarantee of patients`` life and health.
KEYWORDS: before blood transfusion; blood viral markers detection; clinical value

参考文献：
[1] 曾代英,袁丁.输血前血液传染病标志物的检测方法和价值分析 [J].中国医药指南,2013,11(17):616-617.
[2] 热阳古力·努尔麦麦提.受血者输血前四项血液传染指标107 例检测结果分析[J].世界最新医学信息文摘:电子版,2013,13(29):220-221.
[3] 王新彩,师天元,郭新胜.输血前血液传播性疾病感染性标志物检测结果分析[J].河南医学研究,2014,23(11):57-59.
[4] DONATI A,DAMIANI E,LUCHETTI M,et al.Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study[J].Crit Care,2014,18(1):87-91.
[5] 安静娜,李冬冬,陈其霞,等.成都地区临床患者输血前传染性标志 物检测结果10 年同期对比分析[J].中国输血杂志,2014,27(4):405-407.
[6] 史尊基,李文超,郭佩.17 084 例术前及输血前感染标志物检测结 果分析与临床意义[J].中国实用医药,2014,9(6):89-90.
[7] 王玲玲,李蕾.乙型肝炎病毒前S1 抗原与其血清标志物检测的临 床价值[J].国际检验医学杂志,2014,35(20):2831-2832.
[8] 张菊芳,刘冬梅,朱斌.血液净化室医护人员的肝炎病毒血清学标 志物阳性情况分析[J].世界感染杂志,2009,9(4):276.
[9] 赵玉锋,李静.对术前、产前及输血前患者进行乙型肝炎表面抗原、 丙型肝炎病毒抗体、人类免疫缺陷病毒抗体及梅毒螺旋体抗体检测 的意义[J].医疗装备,2016,29(10):82-83.
[10] 陈生,于青,张政,等.维持性血液透析患者血液乙型肝炎表面抗原 阳性的危险因素及对肝功能的影响[J].中国血液净化,2009,8(11):601-604.
[11] 潘艳.受血者输血前血源性传染病5 项指标检测结果分析[J].检 验医学与临床,2009,6(3):216-217.
[12] 唐任光,黄庆,李荣颜,等.输血前传染病标志物检测在预防和控制 医院感染及临床输血纠纷中的作用[J].现代医药卫生,2009,25(2):218-219.